Longevity Therapeutics 2019: "Enhancing & Accelerating Aging Research & The Development of Therapies Targeting Age-Related Diseases"

The inaugural Longevity Therapeutics symposium brought together leading biotech drug developers, academics, investors and pharma companies engaged in creating therapies targeting age-related conditions.

Sessions focused on specific challenges facing these efforts, including discovery, preclinical activities, translational research, clinical development, and regulatory and commercial considerations, and provided a wealth of details about the most recent developments in this space.

Panel discussion: "Extending Human Lifespan" at JPM 2019

The J.P. Morgan Healthcare Conference held in San Francisco this month included a breakout session entitled “Extending Human Lifespan,” sponsored by BIOAGE and Felicis Ventures.

The centerpiece of the event was a panel discussion among five luminaries of the aging field:

  • Laura Deming, founder of Longevity Fund and Age1

  • Simon Melov, professor at the Buck Institute for Research on Aging

  • Aydin Senkut, founder and managing partner of Felicis Ventures

  • Kristen Fortney, founder and CEO of BIOAGE

  • Sonia Arrison (moderator), author of “100 Plus: How the Coming Age of Longevity Will Change Everything”